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TDP-43Alterations in TDP-43 are commonly found in patients suffering from amyotrophic lateral sclerosis (ALS) and the
genetic suppression of the conserved homologue in Drosophila (TBPH) provokes alterations in the functional
organization of motoneuron synaptic terminals, resulting in locomotive defects and reduced life span. To gain
more insight into this pathological process, it is of fundamental importance to establish when during the ﬂy
life cycle the lack of TBPH affects motoneuron activity and whether this is a reversible phenomenon. To achieve
this, we conditionally expressed the endogenous protein in TBPHminusDrosophila neurons and found that TBPH
is a short lived protein permanently required for Drosophilamotility and synaptic assembly through the direct
modulation of vesicular proteins, such as Syntaxin 1A, indicating that synaptic transmission defects are early
pathological consequences of TBPH dysfunction in vivo. Importantly, TBPH late induction is able to recover
synaptogenesis and locomotion in adult ﬂies revealing an unexpected late-stage functional and structural
neuronal plasticity. These observations suggest that late therapeutic approaches based on TDP-43 functionality
may also be successful for the human pathology.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The RNA-binding protein TDP-43 is the primary component of the
insoluble protein aggregates present in themajority of patients affected
by amyotrophic lateral sclerosis (ALS) and fronto-temporal lobar
degeneration (FTLD) (Neumann et al., 2006). More recent studies
have shown that dominantly inherited genetic mutations within the
coding region of TDP-43 were associated with the neurological symp-
toms present in some ALS and FTLD patients (Sreedharan et al., 2008).
Since then, a large number of successive publications illustrating differ-
ent aspects of TDP-43 biology and its role in ALS and FTLD have helped
to elaborate the rising consensus that TDP-43 protein is causally linked
to neurodegeneration.
TDP-43 is a 43 kDa protein of the hnRNP family, its structure and
function are conserved through evolution from insects to men. It pos-
sesses two RNA recognition motifs (RRM1 and RRM2) that are required
for its molecular function in vivo (Buratti and Baralle, 2001, 2012;
Godena et al., 2011). In normal tissues, TDP-43 localizes in the cell
nucleus together with other RNA processing proteins. On the contrary,alle), fabian.feiguin@icgeb.org
ect.com).
This is an open access article under thin FTLD and ALS affected brains TDP-43 suffers a series of pathological
modiﬁcations that include abnormal ubiquitylation, phosphorylation,
cytoplasmic and nuclear aggregation in sarkosyl-insoluble TDP-43
clusters, proteolytic cleavages yielding TDP-43 C-terminal peptides,
and altered intracellular distribution with loss of its typical nuclear lo-
calization (Arai et al., 2006; Geser et al., 2009; Neumann et al., 2006).
There is some evidence that neurons with TDP 43 cytoplasmic aggre-
gates display a depletion of this protein in thenucleus and hence a prob-
able loss of function. On the contrary, increased levels of TDP-43 were
described in the spinal cord and in the cerebrospinal ﬂuid (CSF) of ALS
patients (Kasai et al., 2009; Swarup et al., 2011), indicating that varia-
tions in the basal levels of this protein are critical for the neuronal func-
tion. Evidences in model systems reinforce but by no means prove this
hypothesis. However, the interpretation of each of these observations
deserves a careful analysis since it is not clear which of these ﬁndings
could be the direct cause of the disease and which might be secondary
to the neurodegenerative process. Thus, despite the efforts towards de-
scribing TDP-43 pathology, the original question regarding whether al-
terations in TDP-43 mediate neurodegeneration through a toxic gain of
function or a loss of normal protein activity remains unsolved.
To test these hypotheses and determine the physiological function of
TDP-43 in vivo,we have previously generated the loss of function alleles
in the Drosophila TDP-43 homologue gene TBPH and found that ﬂies
without TBPH activity presented uncoordinated movements ande CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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et al., 2012; Lin et al., 2011). At the molecular level, these functional
alterations were accompanied by modiﬁcations in the organization of
the synaptic microtubules inside the terminals buttons. Moreover, we
described that these defects were due to the down-regulation of the
microtubule-associated protein MAP1B/futsch. This regulation seems
to be achieved through a direct interaction of TBPH with futschmRNA,
implying that a complete loss or a reduction in TDP-43 function within
the cell could lead to ALS or FTLD symptoms through defects in the pro-
cessing of TDP-43 target mRNAs that codify for speciﬁc synaptic or
cytoskeleton-associated proteins, essential for neuronal development
and/or endurance (Arnold et al., 2013; Godena et al., 2011; Hazelett
et al., 2012).
In correspondence with this view, a fundamental question to under-
stand the physiological role of TDP-43 in vivo aswell as themechanisms
behind the pathogenesis of ALS and FTLD, is to know whether the
alterations described in TBPH minus ﬂies were originated from defects
in the protein function during neuronal differentiation, suggesting
a temporary role for TBPH in neurodevelopment, or to determine
whether TBPH is permanently required in mature neurons to prevent
neurodegeneration.
To answer these fundamental questions,we have nowused different
genetic methodologies like the Gene-Switch and the TARGET technolo-
gy (McGuire et al., 2004; Nicholson et al., 2008; Poirier et al., 2008) to
manipulate TBPH expression in the nervous system at discrete temporal
phases and analyze the capacity of the protein to induce or prevent the
neurological phenotypes described in TBPH null ﬂies either during
development or in the adult life. This approach allowed us to deﬁne
the critical periods of TBPH function as well as to characterize the
early events that lead to neuronal dysfunction in the absence of TBPH.
Materials and methods
Fly strains
All ﬂies were kept on standard cornmealmedium and the genotypes
of the used animals are listed below:
W1118 (wild type), w; tbphΔ23/CyOGFP, w;;elav-GS GAL4, w;elav-
GAL4, w;;elav-GAL4, w;;D42-GAL4, w;GMR-GAL4, w;tubulin-GAL80TS,
w;;tubulin-GAL4, UAS-Dcr-2, w;UAS-TBPH; w;;UAS-TBPHF/L, w;;
UAS-mCD8::GFP, w;;UAS-TBPH RNAi (ID38379), w;;UAS-Syx, w;;UAS-
TDP-43, w;;UAS-TDP-43A328T, w;;UAS-TDP-43M337V, and w;;UAS-TDP-
43G348C. All TDP-43 constructs were Flag tagged and EcoRI-XbaI cloned
in the pUASTattB plasmid (5xUAS, GenBank: EF362409) and transgenic
ﬂies were generated by standard embryo injection (Best Gene Inc.)
through PhiC31 integrase-mediated transgenic system. The same
estimated cytosite, 86Fa, on the third chromosome has been selected
for all constructs (Bischof et al., 2007).
Larval movement
Wandering third instar larvae were selected individually, washed
and gently transferred to the center of a Petri dish (94 × 16) with a
layer of 0.7% agarose in distilled water. After a period of adaptation
(30 s), larvae were analyzed measuring the number of peristaltic
waves during a period of 2 min. A fresh Petri dish was used for each
genotype (Feiguin et al., 2009).
Climbing assay
Flies were assessed measuring their negative geotaxis movement.
Aged synchronized adult ﬂieswere transferred in a 50ml cylinderwith-
out anesthesia. After a period of adaptation of 30 s, climbing ability has
been scored counting the ﬂies that reach the top of the cylinder (10 cm)
in 15 s. Flies were assessed in batches of 20, three trials were performed
on each test (Feiguin et al., 2009).Walking assay
3 day-oldﬂieswere placed in a 145mmPetri dishmarkedwith 1 cm
square grid. After a period of adaptation of 30 s, locomotion was quan-
tiﬁed as the number of squares crossed during a period of 30 s
(Feiguin et al., 2009).
RU486-induction protocols
Feeding larvae
A stock solution of 10 mM RU486 in 95% ethanol was added during
ﬂy food preparation. Control groups have been fed in a standard
cornmeal medium containing vehicle only (ethanol). Parental ﬂies
have been left for 6 h in tubes, during which an age-synchronized
embryo population has been collected. Embryos were grown at 25 °C
on standard cornmeal medium containing RU486 (0.1 μM). The larvae
were kept in drug food for a period in accordance to the needs of the
experiment, then were transferred into normal food.
Feeding adults
RU486was diluted to theﬁnal concentration in 2% sucrose and the so-
lution has been added on the surface of a standard cornmeal medium to
feed adults. Newborn ﬂies were collected for 6 h and then transferred in
tubes containing the drug (Osterwalder et al., 2001; Roman et al., 2001).
Target system
Larvae
We have generated, by standard genetic crosses, ﬂies carrying a
single copy of the tubP-GAL80TS construct, a GAL4 driver and a UAS-
transgene. We have grown a synchronized population of larvae kept
in an incubator at 18 °C to repress GAL4-mediated transcriptional
activation of UAS transgene. In mature larvae (L3) stage we induced
the RNAi against TBPH performing a temperature shift from 18 °C to
29 °C. For each experiment a group of control (expressing an unrelated
transgene) has been shifted at 29 °C and another control group
(expressing UAS-target transgene) has been maintained at 18 °C
(McGuire et al., 2004).
Adults
Embryonic, larval and pupal stages were maintained at 18 °C, new-
born ﬂies were collected for 1 day and then transferred at 29 °C or
31 °C. The same controls used in larvae experiments were applied in
adult experiments.
Immunohistochemistry
NMJ larvae were dissected in HL-3 (Feng et al., 2004), ﬁxed for
20 min in 4% formaldehyde (5 min in methanol for anti-GluRIIA) and
labeled with antibodies. Images were captured on a Zeiss 510 Meta
confocal microscope with a 63× 1.4NA oil lens and labeling intensities
normalized to anti-hrp labelingwere determinedwith ImageJ. Numbers
of accumulations per synaptic area were manually quantiﬁed. The
resulting area was normalized to the vesicle marker area. Dilutions of
antibodies are reported below: anti-Flag M5 (Sigma 1:200); anti-TBPH
(in house 1:200); anti-GFP (Invitrogen 1:200); anti-Syn 3C11c (DSHB
1:15); anti-Syx 8C3s (DSHB 1:15); anti-CSP2c (DSHB 1:50); anti-BRPs
(DSHB 1.50); anti-Futsch 22C10s (DSHB 1:50); anti-Dlg 4F3c (DSHB
1:250); anti-Elav (DSHB 1:250); and anti-HRP (Jackson 1:150). Second-
ary antibodies: Alexa Fluor® 488 (mouse, rabbit 1:500) and Alexa
Fluor® 555 (mouse, rabbit, rat 1:500).
Pre- and postsynaptic marker quantiﬁcation
Larvae used for these analyses were processed simultaneously for
immunohistochemistry and confocal images were acquired under
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A2) were used for quantitative analysis. Samples were double labeled
with anti-HRP and the marker. The mean intensity of both the marker
and the hrp has been quantiﬁed, and a ratio has been calculated. To
quantify the cluster volume of Bruchpilot and Glutamate Receptor IIA
a ratio has been calculated between the volume occupied by themarker
inside a single bouton and the total volume of the analyzed bouton
(adapted from Diaper et al., 2013; Thomas et al., 1997). Images were
processed with ImageJ, and then statistically analyzed using Prism.Western blot
Proteins were extracted from adult heads or larval brains squeezed
in a lysis buffer 1×. Thematerial (8–10 μl/head or brain) was processed
with a lysis buffer 1× (1.5× Lysis buffer solution: 225mMNaCl, 15 mM
Tris, 7.5 mM EDTA, 15% glycerol, 7.5 mM EGTA, 75 mM NaF, 6 M urea,
7.5mMDTT and protease inhibitors). Lysateswere clariﬁed by a centrifu-
gation step at 6 °C. The quantiﬁcation of the proteinswas performedwith
Quant-iT™ Protein Assay Kit (INVITROGEN), following the recommend-
ed procedure. Extracted proteins were separated in SDS polyacrylamide
gels and blotted on 0.2 μm nitrocellulose membrane (Sigma-Aldrich).
Membranes were overnight blocked in 5% non-fat dried milk in TBS-T
and subsequently incubated with primary antibodies properly diluted:
anti-Flag M5 (Sigma 1:1000); anti-TBPH (in house 1:2000); anti-Syn
3C11c (DSHB 1:4000); anti-Syx 8C3s (DSHB 1:2500); anti-CSP2c (DSHB
1:9000); anti-BRPs (DSHB 1:2000); anti-Dlg 4F3c (DSHB 1:15,000);
anti-Tubulin (Calbiochem 1:4000); and anti-Actin (Sigma 1:1000). Goat
anti-rabbit and anti-mouse IgG HRP conjugated were used as secondary
antibodies (Pierce 1:50,000). Detection was done with Femto Super Sig-
nal substrate (Pierce). Protein bands were quantiﬁed using NIH ImageJ.
The intensity of the protein bands was calculated with regard to the
equivalent control band. In every lane the mean percentage obtained
out of three experiments has been shown normalized to control.Immunoprecipitation and RNA identiﬁcation by RT-PCR
The same procedure described in (Godena et al., 2011) has been
followed. Brieﬂy, protein G magnetic beads (Invitrogen) were coated
with anti-Flag monoclonal antibody (Sigma). The prepared beads and
head extracts were mixed and incubated for 30 min at 4 °C. After the
washes, bounded RNA transcripts were extracted with DynaMagTM-
Spin (Invitrogen). Trizol extraction of RNA has been performed,
followed by DNase treatment (Promega RQ1#M610A) and oligo-dT
retro-transcription with Superscript III First-Strand Synthesis for
RT-PCR (Invitrogen #1808-051). Gene speciﬁc primers were
designed for ampliﬁcation:Synapsin 5′ACCAGACCATCGTACTCAC3′ and 5′CCGAAAATCATATCGGCATCC3′
Syntaxin 5′TGTTCACGCAGGGCATCATC3′ and 5′GCCGTCTGCACATAGTCCATAG3′
csp 5′CCGATAAGAACCCGGACAATG3′ and 5′TCACGGCACAGCAGATAAC3′
rpl-52 5′GAAAATAACAAAGATCTGCTTGGCC3′ and 5′AAGTGGCCCTTGGGCTTC
AG3′
rpl11 5′CCATCGGTATCTATGGTCTGGA3′ and 5′CATCGTATTTCTGCTGGAAC
CA3′In order to calculate the enrichment fold, initially, all data were nor-
malized to the respective inputs. The signal was represented by how
manymore fold increase wasmeasured compared to the control signal.
The enrichment was calculated according to the following equation:
ΔCT = CT(target)− CT(normalized).
The results were derived from three independent immunoprecipita-
tion experiments.Quantitative real-time PCR analysis
Total RNA was extracted from adult heads of wild type and TBPH
minus alleles by using the KIT QIAGEN RNeasy Microarray tissue
mini kit (code 73304). cDNA was synthesized using random primer
and oligo-dT with Superscript III First-Strand Synthesis for RT-PCR
(Invitrogen #1808-051), using the same protocol described above.Results
Temporal analysis of TBPH requirements in the Drosophila nervous system
To determine the temporal requirements of TBPH function in
the nervous system we ﬁrst of all utilized the Gene-Switch (GS)
RU486-inducible GAL4 system to restore transgenic expression of the
Drosophila TDP-43 homologue in ﬂy CNS at physiological levels in
temporally controlled manner (McGuire et al., 2004; Nicholson et al.,
2008; Poirier et al., 2008).
For these experiments we generated ﬂies carrying the neuronal spe-
ciﬁc driver elav-GS GAL4 in TBPHminus background (GS-TB: tbphΔ23/−;
elav-GS GAL4/UAS-TBPH) and treated GS-TB and wild type ﬂies, with
different concentrations of RU486 (0.05 to 0.25 μM) dissolved in the
ﬂy food immediately after embryogenesis and throughout the subse-
quent larval stages. We found that 0.1 μM of RU486 induced transgenic
expression of TBPH at comparable levels with the endogenous protein
(Fig. 1A) in third instar larval brains (L3). This dosewas sufﬁcient to res-
cue larval locomotion (Fig. 1B), NMJ growth (Figs. 1C–E), MAP1B-futsch
protein levels and cytoskeleton organization inside synaptic buttons
compared with ﬂies treated with different doses of RU486, ethanol
(not induction of transgenic TBPH protein) or ﬂies expressing the
RNA-binding defective version of TBPH (TBPHF/L) which presented little
or no differences compared to TBPH mutants alone (Figs. 1F–J).
Having conﬁrmed the reliability of the Gene-Switch system to
rescue TBPH minus phenotypes we used this methodology to deﬁne
the temporal requirements of TBPH in Drosophila locomotion and NMJ
formation in vivo.
For these experiments,we induced transgenic TBPHexpression in the
nervous system of TBPH mutant ﬂies through precise periods of time
during development (Fig. 2A) and analyzed the levels of protein expres-
sion at the end of the drug treatments as well as at the end of larval pe-
riod or L3 stages (96–100 h after egg laying [AEL]) (Figs. 2B,C). The
genetic rescue capacity obtained by TBPH expression was also evaluated
at the end of larval development (Fig. 2D). We found that transient ex-
pression of the endogenous protein in TBPH null mutant backgrounds
for 48 or 72 h AEL throughout the ﬁrst and second instar larval stages
(L1 and L2 respectively, when axonal growth and synaptogenesis takes
place) failed to rescue larval locomotion (Fig. 2D) and NMJ assembly at
the end of larvae development (L3) (Fig. 2Fiii,iv), compared with
RU486 constitutively treated animals (Figs. 2D,Fvi). Interestingly, west-
ern blot analysis on larval brains revealed that transgenic TBPH protein
was effectively induced immediately after RU486 treatments but
completely disappeared from L3 brains at the end of the third instar lar-
val stages (Figs. 2B,C), indicating that the half-life of the protein was
lower than 24 h. In agreementwith these results, longer drug treatments
(92 hour AEL) showed a gradual reduction of TBPH protein levels from
L3 larval brains 6 h after RU486 removal from the ﬂy food, this fact be-
comes more evident 12 h after drug release to completely disappear by
24 h post-treatment (Fig. 2C). Quantitative analysis of the normalized
TBPH/actin intensity values of three different experiments reported in
Fig. 2E demonstrated that the half-life of the protein was approximately
12 h, implying that this is a short-lived protein and, moreover, consider-
ing the anatomical consequences of TBPH activity in the functional orga-
nization of NMJ (Figs. 2D,F) we conclude that TBPH is permanently
required in the nervous system to regulate the functional organization
of motoneuron synaptic connections.
Fig. 1.Targeted TBPHneuronal expression at endogenous levels rescued larvalmotility, presynaptic grow andmicrotubule organization. (A)Western blot analysis of L3 brains probedwith
anti-TBPH and alpha-tubulin showing that 0.1 μM of RU486 induced TBPH transgenic protein expression at equivalent endogenous TBPH levels compared to control or 0.05 μM RU486
treated brains. Genotypes: W1118 (control), homozygous TBPH null allele, tbphΔ23/−; elav-GS GAL4/UAS-TBPH (GS-TB). Treatments: GS-TB fed ethanol vehicle (GS-TB + ET) or RU486
(GS-TB + RU) at different concentrations in μM. The histogram represents the quantiﬁcation of normalized values on tubulin, these quantiﬁcation numbers are reported below each
lane. n = 3. (B) Measurement of peristaltic waves in L3 larvae showed a complete recovery of larval motility using 0.1 μM of RU486 while a lower dose (0.05 μM) was not sufﬁcient
and 0.25 μM administration showed toxic effects. Equivalent expression of the RNA binding defective isoform of TBPH, tbphΔ23/−; elav-GS GAL4/UAS-TBPHF/L (GS-TBF/L) was unable
to rescue the phenotypes. n= 30 larvae, *p b 0.05, **p b 0.01 and ***p b 0.001 calculated by one-way ANOVA. (C) Confocal images of NMJ inmuscle 6/7, abdominal segment II in L3 larvae
(96–100 h AEL) probedwith the neuronal marker hrp, showed a signiﬁcant rescue of presynaptic branches and 1b boutons in GS-TB+ RU 0.1 μM larvae (iii) compared to controls (i), GS-
TB + ET (ii), or (iv) GS-TBF/L + RU 0.1 μM. (D,E) Quantiﬁcation of NMJ morphology. (F–I) Similar confocal images of L3 NMJs showing the distribution of the microtubules-associated
protein futsch (22C10, red) and hrp (green) in synaptic terminals of (F) controls, (G) GS-TB + ET, (H) GS-TB + RU 0.1 μM and (I) GS-TBF/L + RU 0.1 μM L3 larvae. (J) Quantiﬁcation
of futsch staining showed the absence of this protein from distal boutons in GS-TB + ET and GS-TBF/L + RU 0.1 μM compared to controls where futsch staining fulﬁlls the inside area
of the synaptic boutons aswell as in TBPH rescued ﬂies. n=15 larvae. **p b 0.01 and ***p b 0.001 calculated by one-wayANOVA. Scale bars: (C) 10 μm, (F–I) 5 μm. Error bars indicate SEM.
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alterations and reduced the life span
The results described before suggest that acute defects in TBPH
function might be sufﬁcient to induce neurological phenotypes inFig. 2. Conditional TBPH expression revealed the physiological requirements and half-life of th
Drosophila larval induction of transgenic TBPH show the points of protein analysis. (B)Western
diately after the 48 h, 72 h and 96/100 h of RU486 or ethanol treatments and the levels of TBPH
induced expression assumed similar levels to the endogenous protein in control brains of secon
normalized protein amount was reported below each lane. (C)Western blot analysis of third in
progressive reduction in transgenic TBPH levels after 6 or 12 h post-treatment. Quantiﬁcation
waves at the end of the third instar larval stage (96–100 h AEL) in response to the temporal exp
imum of 12 hour drug release during the L3 stages guaranteed a complete recovery of larval mo
(E) TBPH protein levels normalized on tubulin at different RU486 release time points were
(F) Analysis of NMJmorphology in L3 larvae (96–102 h AEL) stainedwith anti-hrp antibodies sh
motoneuron synaptic terminals (Fiii and iv) compared to wild type (Fi). On the contrary, ﬂ
(Fv, GS-TB + RU + rel12h) were able to completely recover their presynaptic architecturDrosophila. This hypothesis is particularly relevant if we consider that
in the majority of the patients with ALS the neurological symptoms of
the disease appear in already differentiated tissues during adulthood.
Therefore, to test this hypothesis we decided to suppress TBPH expres-
sion exclusively in adult tissues. For these experiments we decided tois protein in developing neurons. (A) Schematic time lines designed to indicate the early
blot analysis of larval brains probedwith anti-TBPH and Actin. Samples were taken imme-
induction in the CNS were compared with the amounts of the endogenous protein. TBPH
d and third instar larvae but appeared undetectable 24 h post-treatment. Quantiﬁcation of
star larval brains similarly probed for TBPH (upper lane) and actin (lower lane) showed a
of normalized protein amount was reported below each lane. (D) Evaluation of peristaltic
ression of the TBPH protein indicates that constitutive expression of the protein or a min-
tility. n = 30 larvae. *p b 0.05, **p b 0.01 and ***p b 0.001 calculated by one-way ANOVA.
plotted in the graph and the half-life of TBPH protein estimated in around 12 h. n = 3.
owed that transgenic expression of TBPH during 48 or 72h after AELwas not able to rescue
ies constitutively treated with RU486 (Fvi, GS-TB + RU) or after 12 h post-treatment
e. Scale bar 10 μm. Error bars indicate SEM.
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gene expression targeting system). This technique is based on the ubiq-
uitous expression of the temperature sensitive version of the GAL80
protein (GAL80TS), a very strong GAL4 repressor that allows activation
of gene expression by a simple temperature shift (McGuire et al.,
2004). In this manner, we used the TARGET system associated to
tubulin-GAL4 to drive the expression of speciﬁc double stranded RNAi
against TBPH exclusively in adult ﬂy tissues. For these experiments,
we combined TARGET tubulin-GAL4 ﬂies with anti-TBPH RNAi strains
and UAS-Dcr-2 to improve the RNAi efﬁciency (TT-TBi: UAS-Dcr-2;Fig. 3.Targeted suppression and overexpression of TBPH in adult ﬂies provoked neurological def
tubulin showed strong reduction of TBPH protein levels after 8 days of TARGET mediated RNA
maintained at restrictive 18 °C temperature. Genotypes: UAS-Dcr-2; tubulin-GAL80TS/+; tubu
Quantiﬁcation of normalized protein amount was reported below each lane. n = 3. (B) Life sp
show no differences in these traits. (C and D) Life span and climbing assays performed in ﬂie
after adult eclosion showed serious neurological alterations in locomotive behaviors with a
ANOVA, life span ***p b 0.001 calculated by log-rank test. Error bars indicate SEM. (E) Western
neurons with the TARGET system probed with antibodies against TBPH and alpha-tubulin. Do n
peratures during development (left panel) or for 10 days at 18 °C during adulthood (medium p
(29 °C in the right panel) show increased levels of TBPH expression. Genotypes: TE-GFP, tubulin-
TB, tubulin-GAL80TS/UAS-TBPH; elav-GAL4/+. The quantiﬁcation of normalized protein amoun
expressing TBPH. Adult ﬂies shifted at 29 °C immediately after eclosion and maintained during
TBPHFL expressing controls. n = 60, **p b 0.01 calculated by one-way ANOVA. Error bars indictubulin-GAL80TS/+; tubulin-GAL4/TBPH RNAi). TT-TBi ﬂies were
grown at 18 °C to maintain the repressive effect of the GAL80 on
tubulin-GAL4 and adult individuals were shifted to 31 °C to abolish the
GAL80 block and induce TBPH-RNAi expression in adult tissues exclu-
sively with tubulin-GAL4. As expected, we observed that TT-TBi ﬂies
eclosed at 18 °C presented similar levels of TBPH protein in head
extracts as control ﬂies expressing Dicer (UAS-Dcr-2) alone (TT-TBc:
UAS-Dcr-2; tubulin-GAL80TS/+; tubulin-GAL4/+) indicating that the
expression of the RNAi against TBPH was not activated during the peri-
od ofﬂy development (Fig. 3A). In agreementwith that,ﬂiesmaintainedects. (A)Western blot analysis ofDrosophila adult heads probedwith anti-TBPH and alpha-
i expression in adult ﬂies at permissive 31 °C temperature compared to controls and ﬂies
lin-GAL4/+ (TT-TBc). UAS-Dcr-2; tubulin-GAL80TS/+; tubulin-GAL4/TBPH RNAi (TT-TBi).
an and climbing assays performed in ﬂies maintained at restrictive temperature (18 °C)
s shifted at two different 29 °C (C) and 31 °C (D) permissive temperatures immediately
n important reduction in their life span. n = 200, ***p b 0.001 calculated by one-way
blot analysis on protein extracts of Drosophila adult heads overexpressing TBPH in adult
ot present alterations in TBPH expression levels after being maintained at restricted tem-
anel). On the contrary, TARGET ﬂies switched during 10 days at permissive temperatures
GAL80TS/UAS-GFP; elav-GAL4/+. TE-TBFL, tubulin-GAL80TS/+; elav-GAL4/UAS-TBPHFL. TE-
ts is reported under each lane. n = 3. (F) Climbing assays performed in TARGET ﬂies over-
10 days presented neurological alterations in locomotive behaviors compared to GFP and
ate SEM.
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compared to controls (Fig. 3B). On the contrary, TT-TBi ﬂies switched
at 31 °C immediately after adult ﬂies eclosion showed a dramatic reduc-
tion in TBPH protein levels that becamemore evident after eight days of
incubation at permissive temperatures (Fig. 3A) indicating that the
TARGET system was able to efﬁciently reduce TBPH protein expression
levels in differentiated adult tissues. More interestingly, we found that
TT-TBi ﬂies eclosed at 18 °C and shifted to 29 °C or 31 °C closely
reproduced, after fewdays, themain neurological phenotypes described
in TBPH minus ﬂies like locomotive deﬁciencies in climbing assays and
reduced life span (Feiguin et al., 2009). Thus, we observed that TT-TBi
ﬂies presented evident locomotion problems in climbing assays after
7 days at 29 °C compared to controls (Fig. 3C). These phenotypes
became more evident after 14 days of uninterrupted TBPH-RNAi ex-
pression or at more permissive temperatures (Fig. 3D) compared with
control TT-TBc ﬂies or TBPH-RNAi ﬂies maintained at restrictive tem-
peratures (18 °C, Fig. 3B). Similar decline in the life span was observed
in these assays, demonstrating that the reduction of TBPH expression
in adult ﬂies was sufﬁcient to induce these pathological modiﬁcations
and early neurodegeneration.
Next, we decided to test whether the acute overexpression of the
endogenous TBPH protein in adult ﬂies was able to affect locomotive
behaviors in climbing assays. For these experiments, we utilized the
TARGET system to overexpress TBPH in adult ﬂy neurons with the
elav-GAL4 (TE-TB ﬂies: tubulin-GAL80TS; elav-GAL4/UAS-TBPH) by
incubating these ﬂies at non-permissive temperatures (18 °C) during
development and moving the adult ﬂies to 29 °C. Thus, we observed
that ﬂies raised at 18 °C and maintained at this temperature during
more than 10 days did not present differences in the levels of TBPH ex-
pression compared to GFP expressing ﬂies (Fig. 3E). On the contrary, we
observed that adult ﬂies similarly developed at 18 °C andmoved imme-
diately after eclosion to 29 °C for about 10 days presented increased
levels of TBPH expression and serious neurological defects in climbing
assays compared with ﬂies overexpressing GFP (TE-GFP: tubulin-
GAL80TS; elav-GAL4/UAS-GFP) or the TBPHFL isoform of TBPH, which
is unable to bind the RNA (Fig. 3F, TE-TBFL: tubulin-GAL80TS; elav-
GAL4/UAS-TBPHFL). These experiments indicated that an acute increase
in TBPH activity in adult stages was able to affect ﬂy locomotion by a
pathological mechanism that depended on the RNA-binding capacity
of the protein. In the same direction, the data strongly supports the
idea that the expression levels of TBPH should be tightly regulated in
order to prevent neurological alterations during the adult life.Neurological deﬁcits caused by lack of TBPH can be rescued through the late
expression of the protein in mature neurons
A fundamental question for potential TDP-43 based therapies to tar-
get ALS/FTD is to know whether a late correction of TDP-43 function
could revert or improve the neurological symptoms. Therefore, we ana-
lyzed nextwhether the reintroduction of this protein inmature animals
could rescue the neurological and structural phenotypes observed in
TBPH loss of function ﬂies. To perform these experiments, we utilized
the Gene-Switch system described above to induce the late expression
of transgenic TBPH protein in TBPH minus neurons at mature third in-
star larval stages (Fig. 4A). Thus, GS-TB ﬂies were treated with either
RU486 or vehicle (ethanol) during 12 or 24 h at mature third instar
(L3) larval stages until the end of the larval period (96–100 hour AEL,
see Fig. 4A). The analysis of protein expression following late activation
of the elav-GAL4 promoter showed a consistent recovery of the TBPH
protein levels inmature larval brains treated with 1mMof RU486 com-
pared to ethanol treated controls (Fig. 4B). The examination of late res-
cued larvae revealed that 12 h of RU486 treatment was sufﬁcient to
induce a dramatic recovery of the normal locomotive behaviors in
these ﬂies compared to control insects expressing the TBPH isoform
that is unable to bind RNA (GS-TBF/L) or ethanol treated ﬂies (Fig. 4C).Most importantly, the NMJ organization in late rescued larvae (after
24 h of promoter activation) showed a clear re-elaboration of motoneu-
ron terminals with the formation of new synaptic branches and the ad-
dition of new synaptic boutons (Figs. 4D–I).We also observed that TBPH
minus synaptic boutons recovered their normal futsch-positive structur-
al organization that included the formation of new cytoskeletal loops
(Figs. 4Fiii, J). These structural modiﬁcations did not recover in ethanol
treated (Figs. 4Eiii, J) or GS-TBPHF/L (Figs. 4Giii, J) expressing controls,
demonstrating that a plastic recovery of the neuronal function and
synaptic organization is possible in differentiated TBPHmutant neurons
at mature larval stages.
Even though the nervous system of L3 larvae is formed by highly
mature and differentiated neurons, we still decided to determine
whether the neurological recovery observed in late larvaewas also pos-
sible in adult ﬂies. For these experiments, we treated immediately
eclosed GS-TB adult ﬂies with two different doses of RU486 in the ﬂy
food and analyzed byWestern blot the expression levels of TBPH induc-
tion in head samples exposed to 60 h of RU486 ingestion comparedwith
untreated or ethanol treated controls (Fig. 4K). In this experiment, we
observed that the expression of the TBPH protein in tbphmutant back-
grounds induced an extraordinary and robust recovery of the climbing
abilities in these animals (Fig. 4L). In particular, these experiments
showed that 2 mM RU486 treated GS-TB ﬂies recovered approximately
60% of their climbing capacities while 5 mM treated ﬂies recovered
more than 80% of their motility (Fig. 4L). These observations demon-
strate that a late functional recovery of neuronal activity in adult stages
was possible in tbph minus ﬂies and suggest that the lack of TDP-43
function may not produce persistent defects in motoneuron function
or motor circuit assemble.
Downregulation of presynaptic vesicular proteins is an early event of TBPH
dysfunction in vivo
A second fundamental issue regarding the neurodegenerative dis-
eases is to understandwhat are the series of events that lead to neuronal
dysfunction and, in the case of TDP-43-mediated pathology, the initial
modiﬁcations that may lead to ALS symptoms and neuronal death. To
determine the premature alterations produced by the lack of TBPH
function in Drosophila neurons we, therefore, decided to characterize
the early alterations provoked in motoneuron synaptic terminals after
the acute silencing of TBPH function in vivo.
For these experiments, we used the previously described TARGET
system to induce the conditional expression of a double stranded RNAi
against TBPH in mature third instar larval neurons. The anti-TBPH RNAi
treatments commenced immediately after these ﬂies reached the L3
larval stages. For these experiments TE-TBi Drosophila embryos (UAS-
Dcr-2; tubulin-GAL80TS, tbphΔ23/+; elav-GAL4, TBPH-RNAi/+)were cul-
tured at restricted temperatures (18 °C) and collected atmature third in-
star larval stages.Mature L3 larvaewere posteriorly shifted to permissive
29 °C temperatures in order to activate the expression of the RNAi
against TBPH. We observed that TE-TBi L3 ﬂies cultured at 18 °C did
not present differences in the brain levels of TBPH protein compared
with TE-TBc controls (UAS-Dcr-2; tubulin-GAL80TS, tbphΔ23/+; elav-
GAL4/+). On the other hand,we found that TE-TBiﬂies after 24 h of tem-
perature switch showed a strong reduction in the neuronal levels of the
endogenous TBPH compared to controls (Fig. 5A). Moreover, we ob-
served that this reduction in protein expression was sufﬁcient to
induce locomotive defects in TE-TBi larvae compared to controls
(Fig. 5B). In contrast with the phenotypes observed in TBPH null L3
larvae, these alterations in ﬂymotility were not associatedwith anatom-
ical modiﬁcations in the number of synaptic boutons or motoneuron
terminal branches at NMJs except for the presence of subtle alterations
in the morphology of the synaptic boutons in TE-TBi ﬂies compared to
controls (Figs. 5C–G), suggesting that functional alterations in synaptic
activity or muscles innervation may precede the anatomical defects
described in TBPH null ﬂies. In order to test this hypothesis, we analyzed
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the expression and/or distribution of molecules involved in synaptic
transmission at Drosophila NMJs (Keshishian et al., 1996; Majumder
and Krishnan, 2010). To achieve this, TARGET TBPH-RNAi treated L3ﬂies and GFP expressing controls were dissected 24 h after RNAi induc-
tion and the intracellular distribution of synaptic protein levels analyzed
by immunocytochemistry. We observed that essential components of
the secretory synaptic machinery like syntaxin (syx), (Wu et al., 1999)
Fig. 5. Acute suppression of neuronal TBPH function in L3 larvae provokes locomotive defects. (A)Western blot analysis on larval brains probed for TBPH and actin showed strong reduc-
tion in endogenous TBPH protein after 24 h of RNAi activation in third instar larval neurons using the TARGET system (genotypes: TE-TBc=UAS-Dcr-2; tbphΔ23, tubulin-GAL80TS/+; elav-
GAL4/+ and TE-TBi + 24 h = UAS-Dcr-2; tbphΔ23, tubulin-GAL80TS/+; elav-GAL4/TBPH-RNAi). Quantiﬁcation of normalized protein amount was reported below each lane. n = 3.
(B) Acute suppression of TBPH by RNAi expression in L3 larval neurons during 24 h induced a drastic reduction in larval motility. n = 30, **p b 0.01 calculated by one-way ANOVA.
(C and D) Analysis of NMJ morphology in L3 larvae (96–100 h AEL) stained with anti-hrp antibodies in (C) TE-TBc and (D) TE-TBi. Images showed that acute silencing of TBPH (24 h)
in neurons does not alter the morphology and the number of branches and boutons, quantiﬁcation shown respectively in (E) and (F). Only a mild signiﬁcant alteration of bouton
shape has been detected, quantiﬁcation in (G). n = 15 larvae, *p b 0.05 calculated by T-test. Scale bar 10 μm. Error bars indicate SEM.
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niﬁcantly downregulated 24 h after the neuronal suppression of TBPH.
Intriguingly, similar experimental conditions induced less signiﬁcant
modiﬁcations in the presynaptic levels of cysteine string protein (csp),
(Dawson-Scully et al., 2007) (Fig. 6C). We also found that the downreg-
ulation of these synaptic markers was progressive and highly dependent
of TBPH function since the constitutive expression of the TBPH-RNAi dur-
ing the complete larval development exacerbated these phenotypes
(Figs. S1A–D). Interestingly, we found that the acute suppression of
presynaptic TBPH did not affect the expression of proteins involved in
the structural organization of the synapses like Bruchpilot (brp) (WaghFig. 4. Late TBPH expression in already well differentiated neurons rescued synaptic grow and
probed with anti-TBPH and alpha-tubulin, before (72 h AEL) and after (96–100 h AEL) drug a
of drug treatment. Quantiﬁcation of normalized protein amount was reported below each lane.
showed a signiﬁcant increase in larval motility compared to similar treatment using TBPHF/L isof
muscle 6/7, abdominal segment II probed for hrp at 72 AEL (i), 96 AEL (ii) and hrp with futsch
presynaptic growth inW1118 L3 larvae from 72 to 96 hour AEL through the addition of newly for
reduced synaptic bouton formation and futsch levels. After 24 h of TBPH induction in
(F) compared to GS-TBF/L + RU treated ﬂies (G). Scale bar 10 μm. (H) Quantiﬁcation of NM
24 h after TBPH activation in L3 larvae from 72 to 96 hour AEL, showed that late induction of
larvae, **p b 0.01 and ***p b 0.001 calculated by one-way ANOVA. (K)Western blot of adult head
h of TBPH induction (right panel). Quantiﬁcation of normalized protein amount was reported b
dependent, recovery of locomotive abilities 60 h after TBPH activation. n = 200, **p b 0.01 andet al., 2006; Wichmann et al., 2008) (Fig. 6D), a protein required in the
organization of the active zones at Drosophila synaptic terminals. In par-
ticular, we observed that neither the distribution of brp nor the levels of
protein intensity were modiﬁed in the synaptic terminals of short term
TBPH suppressed ﬂies or in constitutively TBPH-RNAi treated insects
(Figs. 6D and S1D), although we cannot exclude the presence of more
subtle morphological changes at the level of the T-bars. Western blot
analysis performed in Drosophila adult heads conﬁrmed this data show-
ing a strong reduction in the total protein levels of the vesicular synaptic
markers syx, syn and csp in TBPH minus neuronal tissues compared
to wild type controls (Fig. 6E). On the contrary, we did not observeﬂy locomotion. (A) Schematic time line of TBPH induction. (B) Western blot of L3 brains
ddition showed no protein detection before drug administration compared to 12 or 24 h
n= 3. (C) Evaluation of peristaltic waves in L3 larvae after 24 and 12 h of TBPH induction
orm. n=30, ***p b 0.001 calculated by one-wayANOVA. (D–G) Confocal images of NMJ in
to observe synaptic bouton detail (square green and red, iii). (D) W1118 showed a robust
m futsch positive (22C10, red in detail) synaptic boutons. (E) GS-TB+ ET larvae presented
GS-TB + RU ﬂies, a vigorous regrowth of the synaptic structures was observed
J terminal branches, (I) 1b boutons and (J) futsch intracellular distribution (cytoskeleton),
TBPH was able to recover NMJ morphology to wild type equivalent condition. n = 15
s probed for anti-TBPH and alpha tubulin before RU486 induction (left panel) and after 60
elow each lane. n= 3. (L) Climbing assay of late rescued adults showed a signiﬁcant, dose
***p b 0.001 calculated by one-way ANOVA. Error bars indicate SEM.
Fig. 6.Acute TBPH suppression in L3 larval neurons induced the downregulation of different presynaptic vesicular proteins. (A) Confocal images of NMJs presynaptic boutons inmuscle 6/7,
II segment, compare control, third instar TE-TBc larvae stainedwith anti-hrp (green) and anti-syntaxin (red), with acute silenced TBPH L3 larvae TE-TBi+ 24 hwhere syx appear strongly
reduced in the synaptic terminals. These differences were quantiﬁed in the graph. (B) Similarly, control TE-TBc larvae stained with anti-hrp (green) and anti-synapsin (red) presented a
signiﬁcant reduction in synapsin levels compared to TE-TBi+24 h larvae and quantiﬁed in (B). (C) Amild decrease in csp stainingwas observed between TE-TBc controls and TE-TBi+24
h acute silenced larvae. (D) No differences instead were found in the intracellular levels or presynaptic distribution of brp in control neurons versus acute silenced ﬂies as reported in the
quantiﬁcation of brp intensity pattern (left graph) and receptor area (right graph). n = 250/300 boutons, *p b 0.05, ***p b 0.001 calculated by T-test. Scale bar 5 μm. (E) Western
blot analysis of adult heads stained with anti-syx (upper left), anti-syn (upper right), anti-csp (bottom left), anti-brp (bottom right) and anti-alpha tubulin as a loading control
(lower panel) independently conﬁrms the speciﬁc reduction of presynaptic vesicular markers in TBPH minus ﬂies (tbphΔ23 and tbphΔ142, second and third lines) compared to wild
type (ﬁrst line) and TBPH rescued neurons (tbphΔ23, UAS-TBPH/tbphΔ23, elav-GAL4, in the fourth line). On the contrary, no changes in protein levels were observed for the structural
protein brp. Quantiﬁcation of normalized protein amount was reported below each lane. n = 3. Error bars indicate SEM.
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105G. Romano et al. / Neurobiology of Disease 71 (2014) 95–109modiﬁcations in brp levels between these different genotypes (Fig. 6E),
indicating that these presynaptic proteins may present a differential
sensitivity to TBPH function.
Finally, genetic rescue experiments conﬁrmed this idea by showing
that neuronal expression of the transgenic TBPH protein in TBPH
minus ﬂies was able to reestablish the wild type levels of the downreg-
ulated syx, syn and csp proteins in adult heads (Fig. 6E) demonstrating
that TBPH posses an important role in the functional organization of
the presynaptic terminals and suggesting that defects in vesicular
membrane-dependent events, like exocytosis, may initiate the patho-
logical symptoms observed in TBPH minus Drosophila.
The presynaptic function of TBPH is required for the differentiation and
maintenance of the postsynaptic structures
During the formation of neuromuscular junctions, the activity of the
presynaptic neurons is permanently required to induce the differentia-
tion of postsynaptic structures in the surface of the subjacent muscles
(Bloch and Pumplin, 1988). This neuronal function mainly involves
the release of different signals, including neurotransmitters, through
vesicular exocytosis, suggesting that the alterations in presynaptic
motoneurons described above may lead to defects in the formation of
postsynaptic structures and muscle denervation.
To address this hypothesis, we decided to analyze the distribution of
different postsynaptic markers in L3 larval NMJs after 24 h of presynap-
tic TBPH suppression. In these experimentswe used immunocytochem-
istry to study the distribution of Dlg, a PDZ domain scaffold molecule
important for the localization of numerous postsynaptic proteins
including the glutamate receptors (GluRs) (Chen and Featherstone,
2005). We observed that in wild type NMJs Dlg concentrates around
the presynaptic terminals in the postsynaptic zone, surrounding the
individual synaptic boutons and establishing well deﬁned structures
in the muscular surface (Koh et al., 1999) (Fig. 7A). In contrast, we
found that the acute suppression of presynaptic TBPH induced dramatic
modiﬁcations in the organization of Dlg which appeared strongly
reduced and abnormally distributed, unable to deﬁne single synaptic
structures like surrounding large groups of boutons or even absent,
uncovering big areas of the presynaptic surface (Fig. 7A). We also
found that these early defects in Dlg distribution became progressively
worst in ﬂies expressing anti-TBPH RNAi from the beginning of the
neuronal development (Fig. S1E), indicating that these modiﬁcations
are highly dependent of the presynaptic levels of TBPH expression.Fig. 7. Acute suppression of presynaptic TBPH in L3 larvae affects the maintenance of postsyn
(presynaptic membranes) in green and with anti-Dlg in red (postsynaptic membranes), in con
silenced TBPH (TE-TBi = UAS-Dcr-2; tbphΔ23, tubulin-GAL80TS/+; elav-GAL4/TBPH-RNAi) show
The quantiﬁcation is reported in the graph. (B) Equivalent alterations were also found in the di
GluRIIA appears diffuse or even disappears from the postsynaptic zone, quantiﬁcation of inte
boutons, **p b 0.01, ***p b 0.001 calculated by T-test. Scale bar 5 μm (A). Error bars indicate SESimilarly, we found that the distribution of the postsynaptic receptor
GluRIIA was affected 24 h after the presynaptic expression of TBPH-
RNAi. In particular, we appreciated that the GluRIIA localizes in
well-deﬁned spots with a ring-shaped outline in wild type controls
(Fig. 7B)while in L3 larvae treatedwith TBPH-RNAi for 24 h, the pattern
of GluRIIA staining becamemore diffuse and irregularwith signiﬁcantly
less ring-shaped spots (Fig. 7B). Identical results were found in TBPH-
RNAi constitutively treated neurons (Fig. S1F), indicating that TBPH
function is continuously required in presynaptic motoneurons to main-
tain the differentiation of the postsynaptic structures. In support of
these observations, we found that transgenic expression of TBPH exclu-
sively in neuronswas sufﬁcient to rescue the postsynaptic defects in Dlg
and GluRIIA distribution observed in TBPH minus NMJs (Figs. S2A–J),
conﬁrming that early defects in motoneuron neurotransmission may
lead to muscles denervation in Drosophila.
TBPH binds syntaxin mRNA to regulate postsynaptic differentiation and ﬂy
locomotion
What remained to be determined was whether the downregulation
of these synaptic proteinswas caused directly by TDP-43 or represented
secondary events after TDP-43 depletion. In order to address the possi-
bility that TBPH may interact with the mRNAs of syx, syn or csp in vivo
we immunoprecipitated neuronal expressed Flag-tagged TBPH with
elav-GAL4 from Drosophila heads and utilized real time quantitative
PCR (qRT-PCR) to measure the mRNA enrichment in these samples
compared to immunoprecipitations performed using the unrelated
protein dREEP or, more representatively, the RNA-binding impaired
isoform of TBPH, called TBPHF/L150–152 (Fig. 8A) (Godena et al., 2011).
Interestingly, we observed an enrichment of syx mRNA in TBPH
immunoprecipitated samples (2.5 folds) compared to syn, csp or the
housekeeping genes rpl-52 and rpl-11 (Fig. 8A), indicating that TBPH
may preferentially interact with syxmRNAbut notwith themessengers
of syn or csp. In agreement with this view, we observed that TBPH-syx
mRNA interactions are lost when similar immunoprecipitations were
performed utilizing the RNA-binding defective form of TBPHF/L150–152
demonstrating that these physical interactions are rather speciﬁc.
Moreover, we observed in both loss of function alleles, tbphΔ23 and
tbphΔ142, a signiﬁcant and consistent reduction in the amounts of syx
mRNA in Drosophila adult heads by qtPCR, compared to wild type con-
trol ﬂies (Fig. 8B). Regarding these results, it is interesting to note the
presence of different clusters of putative TBPH binding sequences (TG)naptic structures. (A) Confocal images of synaptic terminal boutons stained with anti-hrp
trol (TE-TBc = UAS-Dcr-2; tbphΔ23, tubulin-GAL80TS/+; elav-GAL4/+) and in acute 24 h
a strong reduction in Dlg intensity with empty areas in the side of the synaptic boutons.
stribution of the glutamate receptor IIA between controls and acute silenced TBPH, where
nsity (left panel) and area (right panel) differences are showed in graphs. n = 250/300
M.
106 G. Romano et al. / Neurobiology of Disease 71 (2014) 95–109both within the 5′UTR and the coding sequence of the syx gene
(Colombrita et al., 2012). These indications togetherwith the co-IP results
plus the observed reduction of syx mRNA and protein levels observed in
TBPH null ﬂies (Fig. 6E) would strongly suggest that the function of TBPH
may contribute to stabilize the subcellular levels of syx mRNA and/or to
possibly promote its translation.
Considering the role of syx in membrane exocytosis these data
strongly suggest that the synaptic defective phenotypes observed in
TBPH mutant ﬂies might be inﬂuenced by the downregulation of syx
levels in vivo.
In order to test this possibility, we analyzed whether transgenic
expression of syx in the TBPH minus backgrounds was able to rescue
the neurological problems induced by the lack of TBPH function
in vivo. Consequently, we observed that neuronal expression of syx
with elav-GAL4 in TBPH null ﬂies (tbphΔ23/−, elav-GAL4; UAS-Syx)
was able to efﬁciently recover the locomotive defects observed in
TBPH minus L3 larvae compared to control ﬂies rescued with GFP
(Fig. 8C). Moreover, we observed that syx-rescued motoneurons were
able to recover the structural defects observed in the distribution and
localization of the postsynaptic protein Dlg (Figs. 8D–G) as well as the
formation of the postsynaptic clusters of GluRIIA (Figs. 8H–K), absent
in TBPH minus terminals. Taken together, these experiments demon-
strate that the regulation of syx levels through the direct interaction
with TBPH is fundamental to promote the formation and differentiation
of neuromuscular synapses.
Intriguingly, we observed that the rescue of syx levels with elav-
GAL4 was not sufﬁcient to recover the pupal lethality associated with
the loss of TBPH function (Feiguin et al., 2009). Nevertheless, we ob-
served that syx expression in adult TBPH hypomorphic alleles, generat-
ed by the induction of anti-TBPH RNAi expression in neurons (tbphΔ23,
elav-GAL4/+; UAS-Dcr-2, TBPH RNAi/UAS-Syx), was able to signiﬁcantly
recuperate the locomotive capacity of these ﬂies in climbing assays
compared to GFP expressing controls (tbphΔ23, elav-GAL4/+; UAS-
Dcr-2, TBPH RNAi/UAS-GFP) (Fig. S3A) conﬁrming the relevance of
these regulatory interactions in adult ﬂies.
Discussion
Although a common characteristic of many neurodegenerative dis-
eases is the late appearance of the neurological symptoms during the
adult life, it is largely unknown whether these alterations originate
from pathological defects that occurred during neuronal development
or later on, in the already differentiated nervous system. In particular,
in the case of ALS and FTD, the temporal requirements for TDP-43 activity
in axon growth, synaptic formation, transmission and maintenance are
still unknown. Clarifying these issues might be essential to understand
ALS pathogenesis, prognosis and evolution, essential aspects required
to design diagnostic tools and effective therapeutic interventions. Our
work, has addressed these two issues using inducible ﬂy systems that
can either shut-off or recover TBPH expression at different time points
during the developmental cycle. In this respect, therefore, our study
mainly focused on the potential consequences of the loss-of-function of
this protein in disease. As discussed previously, however, another possi-
bleway throughwhich TDP-43 could play a role in disease is represented
by its eventual overexpression and subsequent pathological conse-
quences due to gain-of-function mechanisms. Regarding this, many
Drosophila models described up to now and recently reviewed by
us (Romanoet al., 2012) have tried to address this issue by overexpress-
ing human TDP-43 either wild-type or expressing disease-associated
mutants in ﬂies. In all these cases, the overexpression of wild type or
mutated TDP-43 had severe consequences, including the loss of
neurons and an age-dependent reduction in motility. How these two
mechanisms act in human disease and whether they act through the
same mechanisms/pathways are not currently known. Nonetheless,
the observation that both can co-exist suggests that in Drosophila
and humans the levels of TDP-43 must be tightly regulated to ensurethat at all times its expression does not fall or increase over a critical
level.
Chronological requirements of TBPH function and neurological plasticity
To study the chronological requirements of TBPH function we
utilized the very well characterized Gene-Switch and TARGET systems
in Drosophila to induce the conditional expression of the TBPH protein
in TBPH null background.
First of all, we observed that constitutive expression of TBPH in
neurons during Drosophila development could completely rescue
motoneuron presynaptic grow and cytoskeleton organization with
the complete recovering of normal locomotive behaviors and synap-
se differentiation. On the contrary, we found that restricted expres-
sion of TBPH immediately after embryogenesis during very well
deﬁned developmental larval stages (24, 48 and 72 h after AEL)
was not sufﬁcient to restore neither ﬂy motility nor synaptic pattern
at the end of the larval period (96–100 hour AEL). Western Blot anal-
ysis demonstrated that TBPH was effectively induced in these ﬂies
but the protein was not able to persist till the end of the larval period,
suggesting that TBPH may represent a short lived protein. In agree-
ment with this idea, we found that longer pulses of TBPH induction
(84–90 h after AEL) allowed us to recover the structural functionality
of the NMJs and to detect the presence of the protein at the end of the
larval period, indicating that TBPH may present a half-life of approx-
imately 12 h in neurons and demonstrating that its presence was
permanently required during neuronal development for the func-
tional assemble of the neuromuscular synapses in vivo. Interestingly,
it should be noted that this half-life of TBPH is extremely similar to
the one recently determined for human TDP-43 wild type (12.6 h)
in differentiated neuronal cells using a pulse chase approach
(Watanabe et al., 2013). This further highlights the similarities be-
tween the ﬂy and human homologues.
These results, however, did not clarifywhether similar requirements
for TBPH function could also be necessary to guarantee the proper
regulation of locomotive behaviors in adult ﬂies. To test this hypothesis
we decided to reduce the activity of TBPH exclusively in adult tissues by
expressing an RNAi against TBPH using the TARGET system. Unlike
Gene-Switch, the TARGET system allows gene expression by modifying
the environmental temperature and we reasoned that this situation
would favor the stable expression of the anti-TBPHRNAi in adultﬂies in-
dependently of their feeding or locomotive behaviors. In this way, we
observed that the acute expression of the RNAi in adult tissues induced
a marked decrease of the endogenous levels of TBPH in adult heads
compared with similar samples maintained at restricted temperatures.
As expected,we found that RNAi expressingﬂies presented strong alter-
ations in climbing assays and in the expected life span compared to con-
trols. These observations indicated that the abrupt reduction of TBPH
activity in adult ﬂies was sufﬁcient to produce a severe neurological
phenotypes similar to the neurological defects observed in ALS patients
and suggested that incidental defects in TBPH activity during any stage
of the adult life could decisively contribute to the appearance of the
main symptoms of the disease.
Secondly, a fundamental question in the ALS ﬁeld is to knowwheth-
er it is possible to recover the neurological phenotypes and/or prevent
the development of the disease by the late reintroduction of TDP-43
activity. For these experiments, we used Gene-Switch to induce TBPH
expression at the end of the larval development adding the activator
RU486 in the food in adult ﬂies. Using these approaches, we found
that the expression of TBPH protein in differentiated L3 neurons was
able to rescue the synaptic defects detected throughout the larval devel-
opment, promoting the regrowth and reassemble of motoneuron func-
tional synapses together with the functional recovery of the alterations
detected in larval motility.
We have also found that similar induction of TBPH expression
in adult neurons was able to dramatically reactivate the locomotive
Fig. 8.Neuronal expression of syntaxin rescued larval motility and synaptic defects in TBPHminus ﬂies. (A) qRT-PCR analysis of mRNAs immunoprecipitated by Flag-tagged TBPH (IP-TB)
and itsmutant variants TBPH F/L (IP-FL). The enrichment-folds of the two housekeeping genes rpl-52 and rpl-11 are 2.96 and 3.50 times respectively for IP-TBwith an average of 3.23 times
of enrichment. Considering this value as the background values for IP-TB, we can conclude that there is no enrichment for synapsin (enrichment level 3.99, 1.2 folds of the background
level), a slight enrichment for csp (enrichment level 5.60, 1.7 folds of the background level), and a consistent enrichment for syntaxin, whose enrichment level is 8.07 2.5 folds of the back-
ground level. Consistently with the inability to bind RNA of themutant variant TBPH F/L there is no enrichment at all for none of the IP-FL. n= 3. Error bars indicate SD. (B) Real-time PCR
quantiﬁcations of the syntaxin transcript levels in the heads fromwild type and the two TBPHminus alleles. Three independent experiments were quantiﬁed and the average is plotted in
the graph. *p b 0.05, **p b 0.01 calculated by one-way ANOVA. (C) Quantiﬁcation of peristaltic waves of third instar larvae expressing syx protein in neurons of TBPHmutant background
rescued larval motility compared to GFP rescued controls (genotypes: tbphΔ23, elav-GAL4/tbphΔ23; UAS-Syx/+ and tbphΔ23, elav-GAL4/tbphΔ23; UAS-GFP respectively). n = 30. *p b 0.05,
**p b 0.01 calculated by one-way ANOVA. (D–F) Confocal images of synaptic boutons stainedwith anti-hrp (green) andwith anti-Dlg (red), (D)wild type, (E) tbphΔ23, elav-GAL4/tbphΔ23;
UAS-GFP/+, (F) tbphΔ23, elav-GAL4/tbphΔ23; UAS-Syx/+, show recovery of the postsynaptic organization and intensity levels of Dlg compared with GFP rescued ﬂies that conserve areas
devoid of Dlg staining (arrowheads), the quantiﬁcation of these events is showed in (G). (H–J) Confocal images of synaptic terminals stainedwith anti-hrp (green) andwith anti-GluRIIA
(red). (H) Wild type, (I) tbphΔ23, elav-GAL4/tbphΔ23; UAS-GFP/+, (J) tbphΔ23, elav-GAL4/tbphΔ23; UAS-Syx/+, show rescue of glutamate receptor levels, postsynaptic cluster distribution
and organization in syx expressing ﬂies compared to GFP rescued controls. (K) Shows the quantiﬁcation of GluRIIA intensity pattern (left graph) and receptor area
(right graph). n = 300/350 boutons, **p b 0.01, ***p b 0.001 calculated by one-way ANOVA. Scale bar 5 μm. Error bars indicate SEM.
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lasting neuronal plasticity remained in TBPH depleted ﬂies. Additional-
ly, we observed that late rescue experiments of TBPHminus phenotypes
required higher levels of TBPH protein expression compared to the en-
dogenous TBPH amounts present in wild type control brains. The origin
of these differences is not completely clear but they may indicate that
neurons depleted of TBPH during long periods may have lost their
sensitivity to the protein function and longer intervals are required to
reactivate the activity of these neurons.
Our results clearly show that late corrections of TBPH activity in
neurons are possible and sufﬁcient to recover the neurological defects
detected in already well differentiated mature ﬂies. These observations
indicate that therapeutic strategies aimed to re-establish or compensate
TDP-43 function could successfully correct neurological defects provid-
ing a pathway to reversibility that should be explored in the therapy of
human ALS patients.TBPH function is essential for pre and postsynaptic differentiation
Taking advantage from the experimental design that allowed us
to manipulate the levels of TBPH expression in a well deﬁned tempo-
ral manner, we decided to analyze the initial events that lead to
neurodegeneration immediately after TBPH downregulation. Our ex-
periments showed that the acute reduction of TBPH levels induced
an immediate drop in L3 larval locomotion that correlated with a
strong decrease in the synaptic levels of the vesicular proteins syx,
syn and csp that was also conﬁrmed in ﬂies constitutively expressing
the anti-TBPH RNAi during the complete period of larval develop-
ment or in adult ﬂies carrying loss-of-function mutations in TBPH
(Figs. S1A–D and 6A–D).
These results strongly suggest that vesicular exocytosis might be
affected in presynaptic neurons treated with anti-TBPH RNAi and
predict that pathological modiﬁcations in synaptic transmission may
occur at the nerve-muscle contacts. To test this hypothesis,we therefore
analyzed whether the molecular organization of the post-synaptic
membranes was affected in the RNAi treated larvae. We found that
the subcellular distribution of both dlg andGluRIIA receptorswas highly
disorganized after 24 h of anti-TBPH RNAi treatments in L3 larvae,
conﬁrming that defects in NMJ maintenance and/or complications in
muscle innervation constitute early events in the degenerative process
that take place after TBPH loss.
In summary, this work shows that TBPH function is permanently
required in presynaptic motoneurons to induce the differentiation
and maintenance of the NMJs and prevent locomotive defects. This is a
situation that is probably not unique to the ﬂy system, because recent
analyses in adult mice have shown that TDP-43 can be found at the pre-
synaptic membrane of axon terminals in the neuromuscular junction
(Narayanan et al., 2013). In addition, just like in ﬂies, the analyses of
mice transcripts following RIP-Chip have shown that in mice TDP-43
binds to RNAs that codes for genes related to synaptic function. This,
together with the localization of TDP-43 protein at axon terminals, sug-
gests a role for TDP-43 in the transport of synaptic mRNAs into distal
processes (Narayanan et al., 2013). Considering the extremely high
functional similarity between human TDP-43 and Drosophila TBPH,
these results suggest that similar alterations could be expected in indi-
vidual suffering of TDP-43 dysfunction and indicate that Drosophila
melanogastermay represent a suitable system to directly test the func-
tional consequences of the ALS-associated modiﬁcations observed in
this protein.
For the reasons described above, we consider that therapeutic
designs aimed to potentiate synaptic transmission or maintain the
physiological activity of TDP-43 function may predictably ameliorate
the symptoms of the disease.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nbd.2014.07.007.Acknowledgments
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